July 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan ~1 min.According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....
March 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation ~2 min.Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....
March 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results ~2 min.Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....
March 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry ~1 min.Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....
March 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry ~2 min.Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....
March 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry? ~2 min.Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....
March 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study ~1 min.Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....
February 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion ~1 min.Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....
February 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development ~1 min.Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....
February 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings ~2 min.ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....
January 25, 2025Is GSK plc GSK an Undervalued Defensive Stock for 2025? ~2 min.GSK plc (NYSE: GSK) has been gaining attention as a potential undervalued defensive stock for investors looking towards 2025....
December 18, 2024AbbVie Inc. ABBV to Acquire Nimble Therapeutics in a Game-Changing Move ~1 min.AbbVie Inc., a leading biopharmaceutical company, has announced its acquisition of Nimble Therapeutics, a pioneer in the field of immunology....
December 17, 2024AbbVie Inc. ABBV to Acquire Nimble Therapeutics, Boosting Immunology Pipeline ~1 min.AbbVie Inc., a renowned pharmaceutical company, has recently announced its plan to acquire Nimble Therapeutics, a leading biotechnology company, in a move to strengthen its already robust immunology pipeline....
December 20, 2024AbbVie ABBV to Acquire Nimble Therapeutics Further Strengthening Immunology Pipeline ~1 min.AbbVie Inc. (NYSE: ABBV) has announced its plans to acquire Nimble Therapeutics, a biotechnology company specializing in antibody drug discovery....
December 22, 2024AbbVie Inc. ABBV : A Steady Income Dividend Stock for Investors ~2 min.AbbVie Inc., a pharmaceutical company specializing in biopharmaceuticals, has been gaining attention from investors as a potential steady income dividend stock....
